Consensus Molecure S.A.

Equities

MOC

PLONCTH00011

Market Closed - Warsaw S.E. Other stock markets 11:55:42 2024-05-15 EDT			5-day change	1st Jan Change
14.72 ^PLN	-4.29%		+1.66%	-24.51%

03-22	Molecure S.A. Announces First Patient in the OATD-01 Phase 2 KITE Study in Pulmonary Sarcoidosis	CI
01-16	Molecure S.A Announces No Grant of Permission to Conduct Phase II Clinical Trials for the OATD-01 Molecule I	CI

Evolution of the average Target Price on Molecure S.A.

Price target over the last 5 years

History of analyst recommendation changes

aa37e2908af18bbe6f54c6ead33.unOCN_m8wxCmoMhjY_Vr8syIQnNlzfScUkwY_wStljA.lwfPW5PjiHfk-r1TU80psJ7CcjQgksTTIiV-vWqY2Xn1Be1UtsiOQuqZhQ~00c98831a652123fd6a3ee8f3c4e0559

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.38 PLN

Average target price

34 PLN

Spread / Average Target

+121.07%

High Price Target

34 PLN

Spread / Highest target

+121.07%

Low Price Target

34 PLN

Spread / Lowest Target

+121.07%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar